acitretin
Print| Trade Name(s): Acitretin; Soriatane | |
| Group 3: Reproductive Hazard | AHFS Class: Keratolytic Agents |
| Formweb: acitretin | |
| Info Links: Chemotherapy Extravasation Policy | |
Disposal:
demo-disposal icons
| ICONS | DESCRIPTION |
 | Black bin |
 | Blue bin |
 | Light blue bin |
 | Green bin |
 | Purple top bin |
 | Red (sharps) bin |
 | Yellow bin |
 | Trash |
 | Controlled Substance (CsRx) bin |
 | Controlled Substance (Cactus) bin |
 | Spill kit |
Black Box Warning:
PPE:
demo-PPE ICONS
| ICON | DESCRIPTION |
 | Gloves (single layer) |
 | Gloves (double layer) |
 | Gown |
 | Hair Cover |
 | Shoe cover (single layer) |
 | Shoe cover (double layer) |
 | Goggles |
 | Face shield |
 | N95 Mask |
 | Surgical mask |
| Hair cover |
 | Full Face Respirator |
 | Powered air purifying respirator |
 | Coverall (Bunny suit) |
Mechanism of Action:
The mechanism of action of acitretin is unknown, however it is believed to work by targeting specific receptors (retinoid receptors such as RXR and RAR) in the skin which help normalize the growth cycle of skin cells.
Reference: Drug Bank
Exposure Risk:
- Causes skin irritation.
- Causes serious eye irritation.
- May damage fertility or the unborn child.
- Environmental hazards
Reference: PubChem
Safety Data Sheet(s):
Supplemental Information:
Only met the NIOSH criteria as a developmental and/or reproductive hazard
Approved on November 22, 2024
